The Pharmaceutical Analytical
Sciences Group

Search

Spring 2006 Presentations

 

  • PASG Subgroup Genotoxic Impurities Update
    Andrew Teasdale, AstraZeneca

  • Creating an analytical experiment workspace with a global IT system
    Gill Crutchington,
    GlaxoSmithKline

  • Stability study management using a global IT system
    Gill Crutchington,
    GlaxoSmithKline

  • An Integrated Approach to Stability Indicating Method Development Utilising Predictive Software and Automated Systems
    Paul Ferguson, Roland Brown, Steven Coombes, Florence
    Normand & Olivier Puissegur, Analytical Research & Development, Pfizer Global Research & Development, Sandwich

  • Software Tools in HPLC Method Development
    Maggi Tebrake, 3M

  • LIMS-CDS link Efficiency gains and complexities
    David Johnson, Analytical Development, AstraZeneca R& D, Charnwood

  • How to roll out a Global LIMS in only 16 months
    George Johnson
    , Pfizer Global R& D, Sandwich, UK

  • Developments in Tablet Automation for 2006
    John Gostick GSK Ware R& D, Andy Walsh AZ Charnwood R& D

  • Automation - the CRO Perspective
    Andrew Gibson, Pharmaceutical Analysis,Covance

  • NMR Imaging: Applications to tablet Formulation
    Abdenour Djemai, Merck Sharp & Dohme

  • Challenges in the Automation of Inhalation Products
    Jon Faulkes, Senior Scientist, Analytical Development, AstraZeneca R& D Charnwood

  • Application of NQR (Nuclear Quadrupole Resonance) to Pharmaceutical Analysis
    Elizabeth Tate, King's College, London

  • Advances in Separation Science (Liquid Phase)
    Stephen Wren and Pierre Tchelitcheff, AstraZeneca R&D Macclesfield

Home | Contact Us | Search